Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 388

1.

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG.

Pharmacol Rev. 2008 Sep;60(3):358-403. doi: 10.1124/pr.107.00107. Review. Erratum in: Pharmacol Rev. 2008 Dec;60(4):582.

PMID:
18922967
[PubMed - indexed for MEDLINE]
Free Article
2.

[Neurobiological and pharmacologic aspects of atypical antipsychotic drugs].

Sümegi A.

Orv Hetil. 2009 Aug 16;150(33):1539-44. doi: 10.1556/OH.2009.28660. Review. Hungarian.

PMID:
19643718
[PubMed - indexed for MEDLINE]
3.

Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, Höschl C.

CNS Drugs. 2006;20(5):389-409. Review.

PMID:
16696579
[PubMed - indexed for MEDLINE]
4.

Antipsychotic drug actions on gene modulation and signaling mechanisms.

Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA.

Pharmacol Ther. 2009 Oct;124(1):74-85. doi: 10.1016/j.pharmthera.2009.06.001. Epub 2009 Jun 21. Review.

PMID:
19540875
[PubMed - indexed for MEDLINE]
5.

Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits.

Dean B, Scarr E.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):217-25. Review.

PMID:
15180482
[PubMed - indexed for MEDLINE]
6.

Conditioned avoidance response in the development of new antipsychotics.

Wadenberg ML.

Curr Pharm Des. 2010 Jan;16(3):358-70. Review.

PMID:
20109144
[PubMed - indexed for MEDLINE]
7.

Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.

Pani L, Pira L, Marchese G.

Eur Psychiatry. 2007 Jul;22(5):267-75. Epub 2007 Apr 6. Review.

PMID:
17419008
[PubMed - indexed for MEDLINE]
8.

The complexity of the dopaminergic synapses and their modulation by antipsychotics.

Leuner K, Müller WE.

Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S15-20.

PMID:
16508891
[PubMed - indexed for MEDLINE]
9.

Drugs in development for the treatment of schizophrenia.

Emsley R.

Expert Opin Investig Drugs. 2009 Aug;18(8):1103-18. doi: 10.1517/13543780903066756. Review.

PMID:
19589093
[PubMed - indexed for MEDLINE]
10.

Preclinical findings with new antipsychotic agents: what makes them atypical?

Jackson DM, Ryan C, Evenden J, Mohell N.

Acta Psychiatr Scand Suppl. 1994;380:41-8. Review.

PMID:
7914047
[PubMed - indexed for MEDLINE]
11.

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.

Reynolds GP.

Acta Psychiatr Scand Suppl. 1994;380:36-40. Review.

PMID:
7914046
[PubMed - indexed for MEDLINE]
12.

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.

Miyamoto S, Duncan GE, Marx CE, Lieberman JA.

Mol Psychiatry. 2005 Jan;10(1):79-104. Review.

PMID:
15289815
[PubMed - indexed for MEDLINE]
13.

The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.

Binder EB, Kinkead B, Owens MJ, Nemeroff CB.

Biol Psychiatry. 2001 Dec 1;50(11):856-72. Review.

PMID:
11743941
[PubMed - indexed for MEDLINE]
14.

The development of new drugs for the treatment of schizophrenia.

Cookson J.

Br J Hosp Med. 1987 Dec;38(6):542-8. Review.

PMID:
2893648
[PubMed - indexed for MEDLINE]
15.

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.

Meltzer HY, Huang M.

Prog Brain Res. 2008;172:177-97. doi: 10.1016/S0079-6123(08)00909-6. Review.

PMID:
18772033
[PubMed - indexed for MEDLINE]
16.

[Neurobiology in the neuropharmacology of antipsychotic drugs].

Tassin JP.

Encephale. 2006 Jan;32 Pt 2:S6-7. French. No abstract available.

PMID:
16800077
[PubMed - indexed for MEDLINE]
17.

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies.

Abi-Dargham A, Laruelle M.

Eur Psychiatry. 2005 Jan;20(1):15-27. Review.

PMID:
15642439
[PubMed - indexed for MEDLINE]
18.

Current status of antipsychotic treatment.

Conley RR, Kelly DL.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):123-8. Review.

PMID:
12769630
[PubMed - indexed for MEDLINE]
19.

Targeting the dopamine D2 receptor in schizophrenia.

Seeman P.

Expert Opin Ther Targets. 2006 Aug;10(4):515-31. Review.

PMID:
16848689
[PubMed - indexed for MEDLINE]
20.

[New pharmacological approaches to the treatment of schizophrenia].

Uzbay IT.

Turk Psikiyatri Derg. 2009 Summer;20(2):175-82. Review. Turkish.

PMID:
19504368
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk